Related Experiment Video
Updated: May 23, 2026

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
Published on: February 7, 2013
Involvement of iron in biofilm formation by Staphylococcus aureus
Mei-Hui Lin1, Jwu-Ching Shu, Hsiu-Yun Huang
1Department of Medical Biotechnology and Laboratory Science, Chang-Gung University, Taoyuan, Taiwan. thea@mail.cgu.edu.tw
Abstract:
Staphylococcus aureus is a human pathogen that forms biofilm on catheters and medical implants. The authors' earlier study established that 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (PGG) inhibits biofilm formation by S. aureus by preventing the initial attachment of the cells to a solid surface and reducing the production of polysaccharide intercellular adhesin (PIA). Our cDNA microarray and MALDI-TOF mass spectrometric studies demonstrate that PGG treatment causes the expression of genes and proteins that are normally expressed under iron-limiting conditions. A chemical assay using ferrozine verifies that PGG is a strong iron chelator that depletes iron from the culture medium. This study finds that adding FeSO(4) to a medium that contains PGG restores the biofilm formation and the production of PIA by S. aureus SA113. The requirement of iron for biofilm formation by S. aureus SA113 can also be verified using a semi-defined medium, BM, that contains an iron chelating agent, 2, 2'-dipyridyl (2-DP). Similar to the effect of PGG, the addition of 2-DP to BM medium inhibits biofilm formation and adding FeSO(4) to BM medium that contains 2-DP restores biofilm formation. This study reveals an important mechanism of biofilm formation by S. aureus SA113.
Insights
1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (PGG) inhibits Staphylococcus aureus biofilm formation by chelating iron. Restoring iron levels with FeSO(4) reverses this effect, revealing iron
Area of Science:
- Microbiology
- Biochemistry
- Medical Science
Background:
- Staphylococcus aureus is a pathogen that forms biofilms on medical devices.
- Previous research showed 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (PGG) inhibits S. aureus biofilm formation.
- PGG prevents initial cell attachment and reduces polysaccharide intercellular adhesin (PIA) production.
Purpose of the Study:
- To investigate the mechanism by which PGG inhibits S. aureus biofilm formation.
- To determine the role of iron in S. aureus biofilm development.
Main Methods:
- cDNA microarray and MALDI-TOF mass spectrometry to analyze gene and protein expression.
- Chemical assay using ferrozine to assess iron chelating activity.
- Biofilm formation assays in the presence and absence of iron and chelating agents.
Main Results:
- PGG treatment induced gene and protein expression characteristic of iron-limiting conditions.
- PGG was confirmed as a potent iron chelator, depleting iron from the culture medium.
- Supplementation with FeSO(4) restored biofilm formation and PIA production in PGG-treated cultures.
- The iron chelator 2,2'-dipyridyl (2-DP) also inhibited biofilm formation, which was reversed by FeSO(4) addition.
Conclusions:
- PGG inhibits S. aureus biofilm formation by chelating iron, thereby limiting its availability.
- Iron is essential for biofilm formation and PIA production in S. aureus SA113.
- This study elucidates a critical mechanism underlying S. aureus biofilm development.
More Related Videos
Related Concept Videos
Biofilms
Microbes and Other Elemental Cycles
Staphylococcal Skin Infections

